RABIROSE IT TAB

About

RABIROSE IT TAB is a combination medication containing Rabeprazole, a proton pump inhibitor (PPI), and Itopride, a prokinetic agent. Rabeprazole works by irreversibly inhibiting the H+/K+-ATPase enzyme system (the proton pump) in gastric parietal cells, leading to a potent and sustained reduction in gastric acid secretion. This action is crucial for healing acid-related damage and alleviating symptoms of acid reflux. Itopride, on the other hand, enhances gastrointestinal motility by inhibiting dopamine D2 receptors and acetylcholinesterase, thereby increasing acetylcholine concentration and promoting gastric emptying.

This dual-action formulation is particularly beneficial for patients suffering from gastroesophageal reflux disease (GERD) who also experience symptoms of impaired gastric motility, such as nausea, vomiting, bloating, or a feeling of early fullness. By simultaneously controlling acid production and enhancing gut movement, RABIROSE IT provides comprehensive relief from a range of upper gastrointestinal discomforts, promoting better digestion and symptom control.

Uses

• Treatment of gastroesophageal reflux disease (GERD).
• Management of dyspepsia with associated nausea and vomiting.
• Relief from acid reflux and heartburn.
• Improvement of gastric motility disorders.

Directions For Use

Take one tablet daily, preferably before a meal, or as directed by your physician. Swallow the tablet whole; do not chew or crush.

Benefits

• Provides effective and sustained acid suppression.
• Enhances gastric emptying and motility.
• Reduces symptoms of nausea and vomiting.
• Alleviates bloating and abdominal discomfort.
• Offers comprehensive relief for GERD with motility issues.
• Promotes healing of esophageal erosions.

Side Effects

• Headache
• Diarrhea
• Abdominal pain
• Nausea
• Constipation
• Dizziness
• Dry mouth
• Rash
• Increased prolactin levels (Itopride)
• Tremor (Itopride, rare)
• Bone fracture risk (long-term PPI)
• Insomnia

Safety Measures

• Alcohol - Alcohol can exacerbate acid reflux and gastric irritation. It is advisable to limit or avoid alcohol consumption while on this medication.
• Pregnancy - Consult your doctor before use if pregnant. Use only if clearly needed, as the safety of the combination is not fully established.
• Breastfeeding - Itopride can pass into breast milk. Consult your doctor to assess the risks and benefits before breastfeeding.
• Liver - Use with caution in patients with severe liver impairment; dose adjustment may be necessary. Your doctor will monitor liver function.
• Kidney - Dose adjustment may be required in patients with moderate to severe kidney impairment, especially for Itopride. Consult your doctor.
• Lung - No direct contraindications for lung conditions, but long-term PPI use has been associated with a slightly increased risk of community-acquired pneumonia.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.